Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2024-06-06 00:00:00 ET · period of report 2024-06-04 · accession 0001674236-24-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-06 | 2024-06-04 | ANIP | CAREY STEPHEN P. | SVP, CFO | S - Sale | $63.58 | -5,000 | 162.0K | -3% | -$317.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-04 | S | D | 5,000 | $63.58 | 161,968 | D | — | — | (F1) The shares were sold in multiple trades at prices ranging from $64.85 to $62.72. The price reported above reflects the weighted average sales price. |